BioAge Labs, Inc. (BIOA) at a glance

BioAge Labs, Inc. (BIOA) is a small-cap Healthcare company. It trades at $9.67, with a P/E of 1.4, a 0% profit margin and revenue growth of 91%. It does not pay a dividend. Vestovix scores it 70/100 overall. Its strongest dimension is Value (95/100) and its weakest is Momentum (30/100).

Price
$9.67
Market cap
$801.9M
P/E ratio
1.4
Dividend yield
None
Beta
n/a
52-week range
$4.55 to $25.96
Vestovix Score70/ 100How this works
Value
95
Growth
94
Income
40
Safety
60
Momentum
30

Other Healthcare stocks

See all